Maria Dusinska has 171 publications at NILU:
2025
2025
2025
2025
2025
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
Editorial for the Special Issue From Nanoinformatics to Nanomaterials Risk Assessment and Governance
2021
2020
2020
2020
2020
2020
2020
2020
Risk governance of emerging technologies demonstrated in terms of its applicability to nanomaterials
2020
2020
2020
2020
2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2018
2018
Science-based risk governance of nanotechnology (RiskGone)
Engineered nanomaterials (ENMs) are covered by REACH/CLP regulations; the general opinion is that the risk assessment (RA) approach routinely used for conventional chemicals is also applicable to ENMs. However, as […]
CeO2 Nanoparticles-assisted stem-based cell therapy: an innovative nanopharmaceutical approach to treat retinal degenerative diseases
The main aim of CELLUX is to develop a novel pharmaceutical based on CeO2 nanoparticles (NPs) eye drops to treat Age Macular Degeneration (AMD) that in combination with stem cell-based […]
Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays (NanoBioReal)
A sound scientific basis is needed to assess the risks to workers and consumers, to inform regulatory bodies and to ensure a responsible development of nanotechnology. Most of the existing […]
Maria Dusinska has 171 publications at NILU:
2025
2025
2025
2025
2025
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
Editorial for the Special Issue From Nanoinformatics to Nanomaterials Risk Assessment and Governance
2021
2020
2020
2020
2020
2020
2020
2020
Risk governance of emerging technologies demonstrated in terms of its applicability to nanomaterials
2020
2020
2020
2020
2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2019
2018
2018
Science-based risk governance of nanotechnology (RiskGone)
Engineered nanomaterials (ENMs) are covered by REACH/CLP regulations; the general opinion is that the risk assessment (RA) approach routinely used for conventional chemicals is also applicable to ENMs. However, as […]
CeO2 Nanoparticles-assisted stem-based cell therapy: an innovative nanopharmaceutical approach to treat retinal degenerative diseases
The main aim of CELLUX is to develop a novel pharmaceutical based on CeO2 nanoparticles (NPs) eye drops to treat Age Macular Degeneration (AMD) that in combination with stem cell-based […]
Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays (NanoBioReal)
A sound scientific basis is needed to assess the risks to workers and consumers, to inform regulatory bodies and to ensure a responsible development of nanotechnology. Most of the existing […]